SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001213900-21-064202
Filing Date
2021-12-08
Accepted
2021-12-08 16:37:35
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT ea151930-424b5_altamira.htm 424B5 376169
2 GRAPHIC image_001.jpg GRAPHIC 8029
  Complete submission text file 0001213900-21-064202.txt   388684
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000 41 (0) 41 729 71 94
Altamira Therapeutics Ltd. (Filer) CIK: 0001601936 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-261127 | Film No.: 211479127
SIC: 2834 Pharmaceutical Preparations